ExLibris header image
SFX Logo
Title: MHC variation and risk of childhood B-cell precursor acute lymphoblastic leukemia
Source:

Blood [0006-4971] Hosking, Fay yr:2011


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Harrison, C. "New genetics and diagnosis of childhood B-cell precursor acute lymphoblastic leukemia." Pediatric reports 3.s2 (2011): 4-. Link to Full Text for this item Link to SFX for this item
2. Haso, W. "Anti-CD22-chimeric antigen receptors targeting B cell precursor acute lymphoblastic leukemia." Blood 121.7 (2012): 1165-1174. Link to SFX for this item
3. Hudson, Thomas J. "Cancer Genome Variation in Children, Adolescents, and Young Adults." Cancer 117.10 (2011): 2262-2267. Link to Full Text for this item Link to SFX for this item
4. Lilljebjörn, H. "New oncogenic subtypes in pediatric B-cell precursor acute lymphoblastic leukemia." Blood : journal of the American Society of Hematology. 130.12: 1395-1401. Link to SFX for this item
5. Fry, Terry J. "A robust in vivo model for B cell precursor acute lymphoblastic leukemia." The Journal of clinical investigation 125.9 (2015): 3427-9. Link to Full Text for this item Link to SFX for this item
6. Correa, Susan E. "Cancer incidence in adolescents and young adults in the United States, 1992–1997." Journal of adolescent health 32.6 (2003): 405-415. Link to SFX for this item
7. Kloss, C. "Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells." Nature biotechnology 31.1 (2012): 71-75. Link to SFX for this item
8. Uhlin, M. "Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant Disease." Clinical infectious diseases 55.8 (2012): 1064-1073. Link to SFX for this item
9. Saha, V. New agents for the treatment of acute lymphoblastic leukaemia. 2011. Link to SFX for this item
10. Pillon, M. "Long-term results of AIEOP-8805 protocol for acute B-cell lymphoblastic leukemia of childhood." Pediatric blood & cancer 56.4 (2011): 544-550. Link to Full Text for this item Link to SFX for this item
11. Li, C. "Personalized medicine - the promised land: Are we there yet?" Clinical genetics 79.5 (2011): 403-412. Link to Full Text for this item Link to SFX for this item
12. Luce, R. "Impact of the cost of cancer treatment: an internet-based survey." Journal of oncology practice 6.2 (2010): 69-73. Link to SFX for this item
13. Li, Q. "Chemically Self-Assembled Antibody Nanorings (CSANs): Design and Characterization of an Anti-CD3 IgM Biomimetic." Journal of the American Chemical Society 132.48 (2010): 17247-17257. Link to Full Text for this item Link to SFX for this item
14. Egner, R. "CANCER IN ADOLESCENTS AND YOUNG ADULTS." JAMA 300.2 (2008): 217-218. Link to SFX for this item
15. Morgan, G. "Benzene and the hemopoietic stem cell." Chemico-biological interactions 153.Sp. Iss. SI (2005): 217-222. Link to SFX for this item
16. Fearon, D T T. "The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity." Annual review of immunology 13.1 (1995): 127-49. Link to Full Text for this item Link to SFX for this item
17. Wilkie, S. "Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling." Journal of clinical immunology 32.5 (2012): 1059-1070. Link to Full Text for this item Link to SFX for this item
18. Conti, R. "Personalized Medicine and Genomics: Challenges and Opportunities in Assessing Effectiveness, Cost-Effectiveness, and Future Research Priorities." Medical decision making 30.3 (2010): 328-340. Link to Full Text for this item Link to SFX for this item
19. Sadelain, M. "PD-1- and CTLA-4-Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses." Science translational medicine 5.215 (2013): 215-215. Link to SFX for this item
20. Hanada, Nicholas i. "Double or nothing on cancer immunotherapy." Nature biotechnology 31.1 (2013): 33-34. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced